Cooperative-Agreement
Cooperative-Agreement funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIH Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
This NIH PAR-26-116 cooperative agreement supports translational research led by extramural investigators that uses NIH Clinical Center infrastructure through a planned collaboration with NIH intramural investigators.
NIH RFA-CA-27-020: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
RFA-CA-27-020 invites advanced development and dissemination of mature cancer informatics technologies through a U24 cooperative agreement, with NCI committing approximately $2.6M in FY2027 for about three awards and a maximum direct cost of $600,000 per project year.
NIH RFA-NS-26-001: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This NIH opportunity funds research that uses expanded-access data from investigational ALS treatments to support studies in patient populations that cannot enter ongoing clinical trials, with $40,000,000 in FY 2026/27 program funding and a four-award cap for the cycle.
NSF 24-573: Focused EPSCoR Collaborations Program (FEC)
A USA-based collaborative federal program that funds interjurisdictional STEM research infrastructure upgrades through EPSCoR-eligible institutions, with a recurring annual full proposal deadline and required letter of intent.
NSF 24-586: National Quantum Virtual Laboratory - Quantum Testbeds (NQVL)
A U.S. National Science Foundation solicitation supporting Quantum Science and Technology Demonstration projects through QSTD Design and QSTD Implementation phases, with phase-specific funding and strict progress dependencies across Pilot, Design, and Implementation.
PAR-25-051: Blueprint Neurotherapeutics Network (BPN) Small-Molecule Drug Discovery (UG3/UH3)
NIH's PAR-25-051 NOFO funds small-molecule neuroscience drug discovery teams in UG3/UH3 phases, with NIH-provided development support through the Blueprint Neurotherapeutics Network.
PAR-27-013: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (U24)
The NHLBI PAR-27-013 funding opportunity supports Data Coordinating Center (DCC) teams that coordinate multi-site investigator-initiated clinical trials in a milestone-driven cooperative agreement, submitted alongside a companion Clinical Coordinating Center application.
PAR-27-015: Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All
A NIH phased cooperative agreement (UG3/UH3) to fund community-partnered interventions that improve oral health through cross-sector data and practice transformation in US communities.
RFA-AR-27-002: HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
The NIH HEAL Initiative seeks a U24 Data Coordination and Integration Center to harmonize and integrate pain-related datasets, including INTERACT consortium outputs, to support evidence-driven pain research and secondary analysis.
RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.